239 related articles for article (PubMed ID: 11326688)
1. Human hematopoietic growth factors: old lessons and new perspectives.
Dempke W; Von Poblozki A; Grothey A; Schmoll HJ
Anticancer Res; 2000; 20(6D):5155-64. PubMed ID: 11326688
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Hassan HT; Zander AR
J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
[TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
Motoyoshi K
Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
[TBL] [Abstract][Full Text] [Related]
9. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
10. Secretion of GM-CSF and M-CSF by human renal cell carcinomas of different histologic types.
Gerharz CD; Reinecke P; Schneider EM; Schmitz M; Gabbert HE
Urology; 2001 Nov; 58(5):821-7. PubMed ID: 11711375
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
12. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
[TBL] [Abstract][Full Text] [Related]
13. Use of hematopoietic growth factors in elderly patients receiving cytotoxic chemotherapy.
Bokemeyer C; Honecker F; Wedding U; Späth-Schwalbe E; Lipp HP; Kolb G;
Onkologie; 2002 Feb; 25(1):32-9. PubMed ID: 11893881
[TBL] [Abstract][Full Text] [Related]
14. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
15. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.
Schwartz GN; Kammula U; Warren MK; Park MK; Yan XY; Marincola FM; Gress RE
Stem Cells; 2000; 18(5):331-42. PubMed ID: 11007917
[TBL] [Abstract][Full Text] [Related]
17. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of hematopoietic growth factors.
Vose JM; Armitage JO
J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
